(Q47639055)
Statements
Dasatinib plus capecitabine for advanced breast cancer: safety and efficacy in phase I study CA180004 (English)
Linda T Vahdat
George Somlo
Lewis C Strauss
William J Geese
William J Gradishar
Alissa Rybicki
12 February 2013